Acute Pancreatitis in a Patient With Ulcerative Colitis on Vedolizumab. Issue 5 (26th February 2020)

• Record Type: Journal Article
• Authors: Lin, Elissa; Katz, Seymour
• Is Part Of: Inflammatory bowel diseases. Volume 26:Issue 5(2020)
• Page Start: e44
• Page End: e44
• Publication Date: 2020-02-26
• Subjects: ulcerative colitis -- vedolizumab -- acute pancreatitis -- drug-induced pancreatitis; Inflammatory bowel diseases -- Periodicals; Colitis, Ulcerative -- Periodicals; Crohn Disease -- Periodicals; Inflammatory Bowel Diseases -- Periodicals; 616.344
• DOI: 10.1093/ibd/izaa042
• Languages: English
• ISSNs: 1078-0998

Abstract

Abstract : Vedolizumab is a humanized monoclonal antibody that is approved for treatment of patients with moderate to severe ulcerative colitis and is thought to be both safe and effective. We present a case of vedolizumab-associated acute pancreatitis in an ulcerative colitis patient.